-
Novel drug bezisterim plans for further study in Long COVID. Here’s how the phase 2 trial came together.
Novel anti-inflammatory drug shows early promise in treating Long COVID cognitive symptoms, fatigue, PEM. The study looked at multiple endpoints and consulted with people living with the disease. Read more…
Recent articles
Get the latest Long COVID news and commentary
Processing…
Success! You're on the list.
Whoops! There was an error and we couldn't process your subscription. Please reload the page and try again.
Check out our weekly podcast, Still Here
Spotify
Apple Podcasts
PocketCasts
iHeartRadio
RSS
Policy & Advocacy
-
Letter to the editors: Concerns about California’s right-to-mask bill
-
Kennedy’s HHS commits to Long COVID, but without clear funding
-
How do you get people to care about COVID-19? Here’s what I’ve learned as an organizer.
-
Left without care: Many Long COVID clinics are closing down in the U.K.
-
The federal government is restricting COVID-19 vaccine access. Here’s what that means for the ongoing pandemic and people with Long COVID.
-
Long COVID is increasing housing insecurity, but support programs fail to help
Science
Covid-19
Health
-
Telehealth is vital for people with Long COVID. Don’t let it disappear.
-
Despite Long COVID’s ongoing impact, research in Colombia is limited
-
“Medically neglected” and “structurally erased”: International network appeals for ME advocate Nevra Elis
-
The future of Medicaid is “really scary” for people with Long COVID
-
International Long COVID conference spotlights biomarker and mechanism research
-
Less than 20% of Long COVID trials involving exercise even mention post-exertional malaise
-
The U.K.’s plan for ME has failed us. Members of parliament must step up.
-
Work until you disappear: Long COVID ensnared me in an exploitative health system
-
We must free Long COVID and the people living with it from the mind-body trap
-
Research ethics boards need urgent training on Long COVID and myalgic encephalomyelitis